Patents by Inventor Alfred Ajami

Alfred Ajami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080108641
    Abstract: Compounds of formula (I) and a method of treating a patient suffering from an inflammatory and/or demyelinating disorders, comprising administering to said patient a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof. Definitions for the variables are provided therein.
    Type: Application
    Filed: August 15, 2007
    Publication date: May 8, 2008
    Inventor: Alfred Ajami
  • Publication number: 20060189546
    Abstract: A method of treating a patient suffering from an inflammatory and/or demyelinating disorders, comprising administering to said patient a therapeutically effective amount of a compound of formula (A) or a pharmaceutically acceptable salt thereof. Definitions for the variables are provided therein.
    Type: Application
    Filed: January 27, 2006
    Publication date: August 24, 2006
    Inventors: Alfred Ajami, Michael Boss, Jesse Paterson
  • Publication number: 20050239816
    Abstract: Disclosed are organic hydroxy acid salts of amonafide: Also disclosed are methods of preparing salts of amonafide and method of treating subjects suffering from cancer.
    Type: Application
    Filed: June 29, 2005
    Publication date: October 27, 2005
    Applicant: Xanthus Life Sciences, Inc.
    Inventors: Alfred Ajami, David Barlow
  • Publication number: 20050059738
    Abstract: A therapeutic composition comprising an alkyl, aralkyl, alkoxyalkyl or carboxyalkyl ester of 2ketoalkanoic acid and a component for inducing and stabilizing the enol resonance form of the ester at physiological pH values is disclosed. The composition of the invention further comprises a pharmaceutically acceptable carier vehicle in which the enol resonance form of the ester is stabilized at physiological pH values. Formulations containing the compositions of the invention permit the successful use of 2-ketoalkanoic acid esters, e.g., pyruvic acid esters, to treat, e.g., is chemic events, shock, organ reanimation, resuscitation and other recognized pyruvate-effective treatments. The compositions of the inventions are also useful in a process for preserving organ parts, organs or limbs removed from a living mammal and in need of preservation, e.g., for later transplantation to an organ recipient.
    Type: Application
    Filed: September 23, 2004
    Publication date: March 17, 2005
    Applicants: Xanthus Life Sciences, Inc., Beth Israel Deaconess Medical Center, Inc.
    Inventors: Alfred Ajami, Carrie Sims, Mitchell Fink